These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11356585)

  • 1. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia.
    Peet M; Brind J; Ramchand CN; Shah S; Vankar GK
    Schizophr Res; 2001 Apr; 49(3):243-51. PubMed ID: 11356585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.
    Bentsen H; Osnes K; Refsum H; Solberg DK; Bøhmer T
    Transl Psychiatry; 2013 Dec; 3(12):e335. PubMed ID: 24346133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study.
    Pawełczyk T; Grancow-Grabka M; Żurner N; Pawełczyk A
    Schizophr Res; 2021 Apr; 230():61-68. PubMed ID: 33684737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results.
    Peet M
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):477-85. PubMed ID: 14623502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods.
    Pawełczyk T; Grancow M; Kotlicka-Antczak M; Trafalska E; Gębski P; Szemraj J; Żurner N; Pawełczyk A
    BMC Psychiatry; 2015 May; 15():97. PubMed ID: 25934131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.
    Peters BS; Wierzbicki AS; Moyle G; Nair D; Brockmeyer N
    Clin Ther; 2012 Jan; 34(1):67-76. PubMed ID: 22212377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia.
    Pawełczyk T; Grancow-Grabka M; Kotlicka-Antczak M; Trafalska E; Pawełczyk A
    J Psychiatr Res; 2016 Feb; 73():34-44. PubMed ID: 26679763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.
    Pawełczyk T; Grancow-Grabka M; Trafalska E; Szemraj J; Żurner N; Pawełczyk A
    Psychopharmacology (Berl); 2019 Sep; 236(9):2811-2822. PubMed ID: 31098654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans.
    Nestel P; Shige H; Pomeroy S; Cehun M; Abbey M; Raederstorff D
    Am J Clin Nutr; 2002 Aug; 76(2):326-30. PubMed ID: 12145002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial.
    Emsley R; Niehaus DJ; Oosthuizen PP; Koen L; Ascott-Evans B; Chiliza B; van Rensburg SJ; Smit RM
    Psychiatry Res; 2008 Dec; 161(3):284-91. PubMed ID: 18962989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
    Davidson M; Saoud J; Staner C; Noel N; Luthringer E; Werner S; Reilly J; Schaffhauser JY; Rabinowitz J; Weiser M; Luthringer R
    Am J Psychiatry; 2017 Dec; 174(12):1195-1202. PubMed ID: 28750582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study.
    Pawełczyk T; Piątkowska-Janko E; Bogorodzki P; Gębski P; Grancow-Grabka M; Trafalska E; Żurner N; Pawełczyk A
    Schizophr Res; 2018 May; 195():168-175. PubMed ID: 29079060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
    Lane HY; Chang YC; Liu YC; Chiu CC; Tsai GE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1196-204. PubMed ID: 16275807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia.
    Emsley R; Myburgh C; Oosthuizen P; van Rensburg SJ
    Am J Psychiatry; 2002 Sep; 159(9):1596-8. PubMed ID: 12202284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation.
    Phang M; Thorne RF; Alkhatatbeh MJ; Garg ML; Lincz LF
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):254-60. PubMed ID: 26803595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid in the treatment of rheumatoid arthritis: A double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil.
    Dawczynski C; Dittrich M; Neumann T; Goetze K; Welzel A; Oelzner P; Völker S; Schaible AM; Troisi F; Thomas L; Pace S; Koeberle A; Werz O; Schlattmann P; Lorkowski S; Jahreis G
    Clin Nutr; 2018 Apr; 37(2):494-504. PubMed ID: 28302406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial.
    Ibrahim FAS; Ghebremeskel K; Abdel-Rahman ME; Ahmed AAM; Mohmed IM; Osman G; Elseed M; Hamed A; Rabinowicz AL; Salih MAM; Elbashir MI; Daak AA
    Epilepsy Behav; 2018 Oct; 87():32-38. PubMed ID: 30170260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects.
    Wallace FA; Miles EA; Calder PC
    Br J Nutr; 2003 May; 89(5):679-89. PubMed ID: 12720588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.